OSHA Bloodborne Pathogens Standard: What Phlebotomists Must Know

The Standard You Need to Know

The OSHA Bloodborne Pathogens Standard is found at 29 CFR 1910.1030. It applies to any worker who has reasonably anticipated occupational exposure to blood or other potentially infectious materials (OPIM). Phlebotomists are squarely in that category.

The NHA CPT exam tests this standard directly. You will see questions about employer obligations, engineering controls, the Hepatitis B vaccine, and post-exposure procedures. Know the structure of this regulation and what it requires.

Key Pathogens Covered

The standard covers blood and other potentially infectious materials. The three pathogens that get the most attention on certification exams are:

• Hepatitis B Virus (HBV) — The most transmissible bloodborne pathogen in occupational settings. Can survive on dried surfaces for up to 7 days. A vaccine is available and employers are required to offer it.
• Hepatitis C Virus (HCV) — No vaccine available. The most common chronic bloodborne infection in the United States. Transmitted primarily through blood-to-blood contact.
• Human Immunodeficiency Virus (HIV) — Lower transmission rate than HBV or HCV per needlestick exposure. Not easily transmitted by casual contact. Antiretroviral post-exposure prophylaxis (PEP) is available if started within 72 hours of exposure.

The average risk of infection from a needlestick with infected blood: HBV is 6-30%, HCV is approximately 1.8%, and HIV is approximately 0.3%. These numbers explain why HBV vaccination is so strongly emphasized.

The Exposure Control Plan

Every employer covered by the standard must have a written Exposure Control Plan (ECP). This is an employer responsibility, not an employee responsibility. The ECP must:

• Identify all job classifications where occupational exposure occurs
• Describe the methods of compliance the employer uses
• List procedures for evaluating exposure incidents
• Be reviewed and updated annually
• Be accessible to all employees

The ECP must also document that input was solicited from non-managerial employees involved in direct patient care when selecting safer needle devices. This became a requirement under the Needlestick Safety and Prevention Act of 2000.

Engineering Controls

Engineering controls eliminate or minimize hazards at the source. They are the primary line of defense and are preferred over work practice controls alone.

• Safety-engineered needles — Needles with built-in shields, retractable mechanisms, or blunting features that activate after use. Employers must evaluate and implement safety devices and document why specific devices were selected or rejected.
• Sharps disposal containers — Puncture-resistant, leak-proof, clearly labeled, and closeable. Must be located as close to the point of use as possible. Never overfill (fill to the manufacturer's fill line, typically 75%). Never reach into a sharps container.
• Biosafety cabinets and splash guards — For procedures with aerosol or splash risk in laboratory settings.

Engineering controls must be inspected regularly, maintained, and replaced when needed. A full sharps container left in use is an OSHA violation and a real injury risk.

Work Practice Controls

Work practice controls change how tasks are performed to reduce exposure risk. Key requirements:

• Hand hygiene after removing gloves, after any skin contact with blood, and before leaving the work area
• No recapping of needles using two hands. One-handed scoop technique or a mechanical recapping device only, when recapping is required at all
• No eating, drinking, smoking, applying cosmetics, or handling contact lenses in areas where exposure to blood is possible
• No mouth pipetting of any potentially infectious material
• Food and drink must be stored separately from blood, specimens, or potentially contaminated equipment
• Blood-contaminated materials must be placed in appropriate labeled containers before transport

Hepatitis B Vaccination

The employer must offer the HBV vaccine series to all employees with occupational exposure at no cost to the employee, within 10 working days of initial assignment to a position with exposure risk.

The employee may decline the vaccine, but must sign a written declination statement. They may change their mind and receive the vaccine later at any time while still employed in an exposure-risk position.

The HBV vaccine is a three-dose series given at 0, 1, and 6 months. Post-vaccination antibody titer testing is recommended to confirm response. Non-responders may need additional doses or alternative post-exposure management.

Post-Exposure Protocol

When an exposure incident occurs (needlestick, cut with a contaminated sharp, blood splash to mucous membranes or broken skin), the following steps apply:

1. Immediate first aid — Wash the wound thoroughly with soap and water. Flush mucous membrane exposures with water or sterile saline.
2. Report immediately — Notify your supervisor and follow your facility's reporting protocol. Timely reporting matters because PEP for HIV must start within 72 hours to be effective.
3. Source evaluation — If the source patient is known and consents, they are tested for HBV, HCV, and HIV. Results inform your post-exposure management.
4. Medical evaluation — The employer must provide a confidential medical evaluation and follow-up at no cost to the employee. A healthcare professional evaluates the exposure and recommends treatment.
5. PEP consideration — For HIV exposure, post-exposure prophylaxis (antiretroviral medication) is recommended. Start within 2 hours, no later than 72 hours.
6. Documentation — The exposure is recorded on the Sharps Injury Log (see below).

Recordkeeping Requirements

OSHA 300 Log: Employers with 10 or more employees must record work-related injuries and illnesses, including needlestick injuries and other bloodborne pathogen exposures, on the OSHA 300 Log. These records are maintained for 5 years.

Sharps Injury Log: Required under the Needlestick Safety and Prevention Act. Must record each needlestick and sharp object injury. Entries must include: type and brand of device involved, department or work area, description of how the incident occurred. The log is maintained confidentially and separate from the OSHA 300 Log. Retained for 5 years.

Medical records: Employee medical records related to occupational exposure must be maintained for the duration of employment plus 30 years.

Annual Training Requirement

Employers must provide bloodborne pathogen training to all exposed employees at the time of initial assignment and annually thereafter. Training must be conducted during working hours at no cost to the employee. It must cover the contents of the standard, the employer's ECP, engineering and work practice controls, PPE use, HBV vaccination information, and post-exposure procedures.

Training records must document the date, topics covered, trainer qualifications, and employee names and job titles. Retained for 3 years.

Practice Questions